Schedule 13D ownership disclosure

Nuo Therapeutics, Inc

Security class unavailable · CUSIP: 67059V100

Event date: 2017-09-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
27.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001683168-17-002438
Form type
SC 13D/A
Filer
Boyalife Investment Fund I, Inc.
CIK
CIK 1683332
Filed
Sep 21, 2017
Reporting period
Sep 11, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub